Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Alteplase Action Pathway
Homo sapiens
Drug Action Pathway
Alteplase is a recombinant plasminogen activator present in human tissue, also known as Activase, Cathflo and Cathflo Activase used to treat emergencies such as myocardial infarction, ischemic stroke and pulmonary emboli. It is administered intravenously and goes to act on plasminogen which acts on fibrin clots to degrade them into fibrin degradation products known as fibrinolysis. Alteplase binds to fibrin and cleaves an arginine-valine bond of plasminogen converting it into its active form and acting on the fibrin matrix. It is metabolized by the liver through receptor-mediated endocytosis. Due to its nature of anticoagulant and antiplatelet activity herbs and supplements with similar activity should be avoided such as garlic, ginger, bilberry, danshen, piracetam and ginkgo biloba.
References
Alteplase Pathway References
Acheampong P, Ford GA: Pharmacokinetics of alteplase in the treatment of ischaemic stroke. Expert Opin Drug Metab Toxicol. 2012 Feb;8(2):271-81. doi: 10.1517/17425255.2012.652615. Epub 2012 Jan 17.
Pubmed: 22248305
Seifried E, Tanswell P, Ellbruck D, Haerer W, Schmidt A: Pharmacokinetics and haemostatic status during consecutive infusions of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction. Thromb Haemost. 1989 Jun 30;61(3):497-501.
Pubmed: 2508258
Dhillon S: Alteplase: a review of its use in the management of acute ischaemic stroke. CNS Drugs. 2012 Oct 1;26(10):899-926. doi: 10.2165/11209940-000000000-00000.
Pubmed: 22950491
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings